Leclercq G, Verhest A, Deboel M C, Van Schoubroeck F, Mattheiem W H, Heuson J C
Biomedicine. 1976 Dec 5;25(9):327-30.
Eleven samples from 7 primary and 4 metastatic male breast cancers were analysed for cytoplasmic oestrogen receptors. Two samples of metastatic cancers were obtained from a same patient 6 months apart. Receptors were assayed by measuring the binding affinity of cytosol fractions for 3H-oestradiol- 17beta. Saturable binding sites were obtained in 6 primary and 1 metastatic cancers. The dissociation constant of the binding reactions were within the range reported for the specific oestrogen receptors from female breast cancers. When present, receptor concentrations varied from 59 to 532 fmoles/mg tissue protein. Competition studies of the binding of 3H-oestradiol- 17beta by excess amounts of unlabelled steroid hormones or antihormones revealed that the receptors were specific for oestrogens and antioestrogens. By all these criteria, receptors from male mammary cancer were identical to those from female breast cancer. Chromosome analysis was performed in 6 patients. All had normal 46 XY male pattern indicating that no conspicuous genetic abnormalities such as those of the Klinefelter syndrome seemed responsible for the presence of the receptors.
对7例原发性和4例转移性男性乳腺癌的11个样本进行了细胞质雌激素受体分析。其中2个转移性癌样本取自同一患者,间隔6个月。通过测量细胞质部分与3H-雌二醇-17β的结合亲和力来检测受体。在6例原发性癌和1例转移性癌中获得了可饱和的结合位点。结合反应的解离常数在女性乳腺癌特异性雌激素受体报道的范围内。当存在受体时,受体浓度在59至532飞摩尔/毫克组织蛋白之间。用过量未标记的甾体激素或抗激素对3H-雌二醇-17β结合进行的竞争研究表明,这些受体对雌激素和抗雌激素具有特异性。根据所有这些标准,男性乳腺癌的受体与女性乳腺癌的受体相同。对6例患者进行了染色体分析。所有患者均具有正常的46 XY男性模式,表明没有明显的遗传异常,如克兰费尔特综合征那样的异常似乎与受体的存在无关。